Skip to main content

Find Clinical Trials

Home
Conditions
Herpes Zoster

Clinical trial condition

Herpes Zoster

Explore clinical trials studying Herpes Zoster. Study availability and eligibility vary by location and protocol.

174 public trials 19 recruiting studies

Refine in advanced search Browse all conditions

Herpes Zoster trial results

Completed

Immunogenicity and Safety of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over

NCT03120364

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +3 more
Locations: Korea University Guro Hospital Seoul, Guro-gu, South Korea

View Trial Details

Completed

Immunogenicity and Safety of Two Lots of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over

NCT03116594

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +3 more
Locations: Korea University Guro Hospital Seoul, Guro-gu, South Korea

View Trial Details

Completed

ZOSTAVAX™ Safety Study in Subjects ≥ 60 Years of Age (V211-020)

NCT00550745

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +3 more
Locations: Not specified

View Trial Details

Completed

ZOSTAVAX™ Administered Concomitantly With PNEUMOVAX™ 23 (V211-012)(COMPLETED)

NCT00535730

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, DNA Virus Infections, +9 more
Locations: Not specified

View Trial Details

Completed

Safety, Tolerability, and Immunogenicity of a Booster Dose of Zoster Vaccine, Live (V211-029)

NCT01245751

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +4 more
Locations: Not specified

View Trial Details

Completed

ZOSTAVAX™ Safety and Immunogenicity in Korean Adults (V211-034)

NCT01556451

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +4 more
Locations: Not specified

View Trial Details

Completed

Safety and Immunogenicity of Zoster Vaccine (ZOSTAVAX™) Made With an Alternative Manufacturing Process (AMP) (V211-042 AM1)

NCT01505647

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +4 more
Locations: Not specified

View Trial Details

Completed

ZOSTAVAX™ in Patients on Chronic/Maintenance Corticosteroids (V211-017) (COMPLETED)

NCT00546819

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +3 more
Locations: Not specified

View Trial Details

Completed

ZOSTAVAX® in Renal Transplant Patients

NCT01137669

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +3 more
Locations: University of Iowa - Vaccine Research and Education Unit Iowa City, Iowa, United States

University of Maryland Baltimore - School of Medicine - Medicine Baltimore, Maryland, United States

Vanderbilt University - Medicine - Infectious Diseases Nashville, Tennessee, United States

View Trial Details

Completed

Safety and Immunogenicity Study of Live Attenuated Vaccine Against Herpes Zoster in Chinese Adults Aged 50 Years and Older

NCT02526745

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +3 more
Locations: Not specified

View Trial Details